RecruitingNCT04603196

Prevalence and Impact of Obstructive Sleep Apnea in Multiple Sclerosis

Sponsor

Beth Israel Deaconess Medical Center

Enrollment

800 participants

Start Date

Jun 20, 2019

Study Type

OBSERVATIONAL

Conditions

Multiple Sclerosis Obstructive Sleep Apnea

Summary

This study will evaluate the influence of sleep apnea on clinical and radiological features of MS. Sleep apnea is associated with hypoxemia during sleep, which is likely detrimental to MS. Clinical data (MRI, lab results, medical history, labs, and sleep studies) of MS patients will be collected and analyzed. This will be done to study correlations between MRI, clinical data, lab studies and sleep studies. There is specific interest in the type of sleep apnea associated with MS, and whether MRI or clinical metrics of MS severity correlate with presence or absence of sleep apnea.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study examines how common obstructive sleep apnea — a condition where breathing repeatedly stops during sleep — is among people with multiple sclerosis (MS), and whether having untreated sleep apnea worsens MS symptoms like fatigue, cognitive difficulties, and overall quality of life. Sleep problems are frequently overlooked in MS patients, and this study aims to highlight their impact and improve care. **You may be eligible if...** - You are over 18 years old - You have a confirmed diagnosis of multiple sclerosis - You are willing to provide written informed consent and participate in the assessment process **You may NOT be eligible if...** - You are unable to provide informed consent (for example, due to cognitive impairment or other circumstances) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04603196

Related Trials

Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)

NCT000012481 location

Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques

NCT027842101 location

Immunoglobulin Deficiency a Treatable Cause of Fatigue in Patients With Multiple Sclerosis (MS)?

NCT053577811 location

Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy

NCT058494671 location

Blood Flow Restriction for Upper Limb Rehabilitation in People With Multiple Sclerosis. A Randomized Controlled Trial (BFRT-EM)

NCT067952301 location